Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

DiabetesMine University 2018 - Program Brochure

741 Aufrufe

Veröffentlicht am

Event program for "DiabetesMine University," held Nov. 1-2, 2018, at UCSF Mission Bay. This diabetes innovation event encompassed our annual #DBMineSummit and #DData ExChange technology forums for leaders in patient advocacy, pharma, DIY tech, regulatory, clinical care, digital health entrepreneurs and more.

Veröffentlicht in: Gesundheitswesen
  • Do This Simple 2-Minute Ritual To Loss 1 Pound Of Belly Fat Every 72 Hours ➤➤ https://tinyurl.com/y6qaaou7
    Sind Sie sicher, dass Sie …  Ja  Nein
    Ihre Nachricht erscheint hier
  • Want to preview some of our plans? You can get 50 Woodworking Plans and a 440-Page "The Art of Woodworking" Book... Absolutely FREE ●●● http://tinyurl.com/y3hc8gpw
    Sind Sie sicher, dass Sie …  Ja  Nein
    Ihre Nachricht erscheint hier
  • Your opinions matter! get paid BIG $$$ for them! START NOW!!.. ▲▲▲ https://tinyurl.com/realmoneystreams2019
    Sind Sie sicher, dass Sie …  Ja  Nein
    Ihre Nachricht erscheint hier
  • Want to preview some of our plans? You can get 50 Woodworking Plans and a 440-Page "The Art of Woodworking" Book... Absolutely FREE ■■■ http://tinyurl.com/y3hc8gpw
    Sind Sie sicher, dass Sie …  Ja  Nein
    Ihre Nachricht erscheint hier
  • I recovered from bulimia. You can too! learn more... ■■■ http://tinyurl.com/yxcx7mgo
    Sind Sie sicher, dass Sie …  Ja  Nein
    Ihre Nachricht erscheint hier
  • Gehören Sie zu den Ersten, denen das gefällt!

DiabetesMine University 2018 - Program Brochure

  1. 1. made possible by: get ready to learn and connect 2018 Innovation Summit & #DData Technology ExChange DMUDIABETESMINE university Nov. 1-2, 2018 • UCSF Mission Bay
  2. 2. 8:10 am BREAKFAST & WELCOME! - host Amy Tenderich 8:45 “The Consumerization of Diabetes” Chris Bergstrom, Boston Consulting Group Digital Health, with leaders from • Fitbit • Onduo • Samsung • Verily GENERAL SESSION PERIOD1 WORKSHOPS WORKSHOP A) Humans, Diabetes Tech and Virtual Reality Dr. Korey Hood, Stanford Diabetes Research Center, on Human Factors and VR in diabetes care WORKSHOP B) Harnessing the Power of Social Media National diabetes nonprofit powerhouse Beyond Type 1, on how to create social media impact 10:30 12:00 pm LUNCH 1:00 “Moving Fast, Breaking Things: Patient Entrepreneurship & Health Design Hubs” - Aaron Sklar, Co-founder of Prescribe Design, with leaders from: • Patient Innovation • UCSD Designing for Health • Jefferson University Health Design Lab WORKSHOP B) Social Media - Repeats WORKSHOP C) Beyond Product Focus: Designing for the Diabetes Experience Joe Cafazzo, UHN Healthcare Human Factors and Thacher Hussain, software developer & patient advocate, on mapping the healthcare experience 2:15 10:15 COFFEE BREAK 3:45 COFFEE BREAK WORKSHOP A) Virtual Reality - Repeats WORKSHOP C) Experience Design - Repeats 4:00 5:30 Day 1 Wrap-Up 5:45-7:30 Learn & Connect! NETWORKING RECEPTION 2:00 COFFEE BREAK GENERAL SESSION PERIOD2 WORKSHOPS PERIOD3 WORKSHOPS GENERAL SESSION AGENDA 2018INNOVATIONSUMMITDMU
  4. 4. 2018 INNOVATION SUMMIT a fresh curriculum on diabetes innovation 5 event host Amy Tenderich, DiabetesMine Amy Tenderich is a journalist, blogger, patient advocate and consultant who start- ed DiabetesMine.com after her diagnosis with type 1 diabetes in 2003. Her site has become a leading online destination for people with diabetes and one of the top health blogs around the country and the world. The site became part of San Francisco-based Healthline Media in January 2015. Amy has made it her personal mission to spur innovation in diabetes care that actually originates with patients. She penned an Open Letter to Steve Jobs in 2007 that went viral, developing into an international crowdsourcing competition called the DiabetesMine Design Challenge, underwritten by the California Health- Care Foundation and supported by IDEO. This culminated in the DiabetesMine Innovation Summit, a unique annual gathering of diabetes stakeholders that Amy organizes and hosts at each Fall in the San Francisco Bay Area, and the bi-annual DiabetesMine D-Data ExChange technology forum. Amy is an adviser to AADE, serving on their Technology Workgroup and Peer Support Communities Com- mittee. She has conducted various research projects highlighting patient needs, with results published in Diabetes Spectrum, the American Journal of Managed Care, and the Journal of Diabetes Science and Technology. She is a regular public speaker and guest lecturer on patient-centered design and related advocacy topics. featured speakers Chris Bergstrom, Boston Consulting Group Chris has a passion for leveraging technology to decentralize healthcare and dis- rupt inefficient business models. He has been an advocate for people with diabe- tes for over 20 years. Having executive experience at Roche Diabetes Care, BD Diabetes Care, and WellDoc, an early pioneer of diabetes digital health. He serves as an advisor to AADE and previously ADA and the Helmsley Trust. He has spoken at many diabetes conferences including ADA, AADE, ATTD, CWD, and the Diabe- tesMine Innovation Summit. Chris also holds 3 patents in diabetes technology. He is recognized in the media as “One of 8 mobile health thought leaders to follow” and a “Top 100 Digital Health Influencer.” Today, Chris helps lead the Digital Health practice at BCG. The BCG digital group has grown to +800 people -- all experienced in building digital companies. BCG partners with large companies to help them innovate at an agile pace, and in just 4 years launched 70 new digital ventures (in and outside of healthcare). Chris holds a bachelor’s degree from Indiana University and an MBA from Columbia University.
  5. 5. 6 DMU diabetesmine university Jordi Parramon, Verily Jordi Parramon, PhD, is Director of Medical Devices at Verily Life Sciences, an Alphabet company. After graduating in Physics and EE, Jordi joined Advanced Bionics, a cochlear implant company in California, to work on world’s smallest neurostimulators (bion). In 2004, he joined the Neuromodulation division of Boston Scientific following the acquisition of Advanced Bionics. In early 2017, Jordi moved to Verily. Throughout his 19+ years in the medical devices field, Jordi has taken increasing levels of responsibility within research and development for Class III active im- plantable neuromodulation devices, including Spinal Cord and Deep Brain Stimu- lators businesses, and now expanding at Verily with broader exposure to healthcare. He currently has over 50+ granted US patents. At Verily, Jordi oversees a number of projects, spanning from Diabetes, Ophthalmology, Surgical Robotics, and Neuromodulation. Susa Monacelli, Onduo As Head of Payor Relations, Susa oversees strategic development initiatives and client relationships. Susa is a long-time change-maker in the healthcare and con- sulting industries, forging partnerships and uncovering visionary solutions as the Executive Director and Development Principal at Blue Cross Blue Shield Associ- ation, a consultant at McKinsey, and a Senior Product Manager at Medsite. Susa holds a BA from Brown University and an MBA from Columbia University.
  6. 6. 2018 INNOVATION SUMMIT a fresh curriculum on diabetes innovation 7 Kevin Jones, Samsung As Senior Director, Digital Health at Samsung Electronics America, Kevin leads a variety of new business and technology initiatives for Samsung with a focus on driving innovations in chronic disease management, ambulatory care and remote patient monitoring. Previously, Kevin was the Director of Business Development at Intel Corporation. As a member of Intel Capital (ICAP), he was responsible for managing several stra- tegic investments across Europe and Asia based out of the London office. He also represented Intel on the Board of Directors of the Wholesale Applications Commu- nity and the Tizen Association. Prior to Intel, Kevin was VP and General Manager of the Mobile Business Unit at Spectel (acquired by Avaya in 2004). Before joining Spectel, Kevin was the Vice President of Marketing and Sales at Groove Mobile (acquired by Livewire Mobile). Kevin has also held a number of senior management positions at Nokia, including General Manager, Mobile Data (based in Helsinki, Finland) and Vice President, Nokia Ventures. Prior to Nokia, Kevin held senior level marketing, sales and engineering positions at Sun Microsystems and Hewlett-Packard. A frequent speaker at industry events, Kevin has presented on a wide variety of topics in computer archi- tecture, digital health, wearables and mobile communications. Kevin holds a degree in Computer Science from California State University. John Moore, Fitbit John Moore is a physician, engineer and the Medical Director at Fitbit. He is the former CEO of Twine Health, a Cambridge-based company recently acquired by Fitbit that created an innovative, proven health coaching platform that empowers people to take control of their health to achieve better outcomes. John studied biomedical engineering and then medicine at Boston University. He left the clinical career path, determined to develop solutions to improve healthcare delivery, and earned a PhD from MIT. The intensive research that he conducted there, at the intersection of health psychology, learning science, and human-com- puter interaction, formed the health behavior change foundation of Twine Health that is now being leveraged at Fitbit.
  7. 7. 8 DMU diabetesmine university workshop a) Humans, Diabetes Tech & Virtual Reality FACILITATORS Korey Hood, Stanford Diabetes Research Center Dr. Hood directs NIH- and foundation-funded clinical research aimed at promoting health and quality of life outcomes for people with diabetes. There are two content threads to his work: 1) construct prevention and treatment programs to address modifiable psychological and family factors that create barriers to optimal diabe- tes management, and 2) optimize the use of devices and technologies to improve health outcomes. Dr. Hood coordinates the Human Factors assessments in Drs. Maahs’ and Buck- ingham’s closed loop studies and is recognized as one of the experts in this area nationally and internationally. These assessments focus on uptake of devices and technologies, and determining strategies to promote uptake and optimize their use. Dr. Hood and his research team have published over 100 scientific articles on these topics and are active presenters at diabetes, behavioral medicine, and advocacy conferences. Dr. Hood also works in clinical and service settings. He is a licensed clinical psychologist and is part of the diabetes care team at Stanford. He is a past chair of the American Diabetes Association’s Behavioral Med- icine and Psychology Interest Group and is currently a member of the Research Policy Committee. He was also a member of the ADA’s Call to Congress in March 2017 and is an Associate Editor for both Diabetes Care and Pediatric Diabetes. Dr. Hood’s work across research, clinical, and service settings is fueled by his experience taking care of his own type 1 diabetes. Diana Naranjo, Lucile Packard Children’s Hospital Diana M. Naranjo, PhD, is Associate Professor of Pediatrics at Lucile Packard Chil- dren’s Hospital at Stanford. As a trained pediatric and adult psychologist working in behavioral medicine, Dr. Naranjo focuses on the psychosocial needs of patients and families with diabetes. She aims to understand barriers and facilitators to care, what developmental demands are important as adolescents transition to adulthood, and how to best provide services that engage young adults and their families. Furthermore, as a Latino-American and fluent in Spanish, much of her clinical work focuses on bridg- ing the healthcare gap for Latino youth and families.
  8. 8. 2018 INNOVATION SUMMIT a fresh curriculum on diabetes innovation 9 workshop b) Driving Social Media for Health Impact FACILITATORS Thom Scher, Beyond Type 1 Thom is the COO at Beyond Type 1, overseeing general operations and corpo- rate partnerships, and has been with the organization since its inception. He also serves as President of the Beyond Type 1 subsidiary, Shop The Drop. Prior to Beyond Type 1, Thom was responsible for overseeing the global brand and content initiatives at wikiHow, a Top 100 website. Before working in tech, Thom started his own fashion­-focused and award­-nominated public relations firm in San Francisco. He is passionate about travel, philanthropy, his alma mater (Stan- ford), and his dog (Kermit). Dana Howe, Beyond Type 1 As the Communications Manager at Beyond Type 1, Dana strives to use social and digital media to amplify the voices of the community and harness our collective power to improve the lives of everyone impacted by Type 1. In the past, Dana has worked as a communications specialist everywhere from ma- jor hospitals to small nonprofits on topics ranging from cancer to pediatric device innovation. Dana studied Biology and Community Health as an undergraduate and went on to complete an MS in Health Communication from Tufts University. She has lived with type 1 diabetes since 2002. When she’s not favoriting your tweets, you can find her skiing, biking or drinking coffee.
  9. 9. 10 DMU diabetesmine university workshop c) Beyond Product Focus: Designing for the Diabetes Experience FACILITATORS Joe Cafazzo, University Health Network Dr. Joseph Cafazzo is Lead for eHealth Innovation and Executive Director and Founder of Healthcare Human Factors, both located with University Health Network (UHN), a teaching hospital of the University of Toronto. As a biomedical engineer, he has spent his entire career in a hospital setting. By observing health- care delivery from the inside, he works on ways to keep people out of hospital by creating technologies that allow for self-care at home. He is an active researcher of the use of technology to facilitate patient self-care of complex chronic conditions such as diabetes, asthma, end-stage renal disease, and congestive heart failure. He has advised and conducted research for public sector policy makers and private sector medical technology companies on the design and safety of technology in healthcare. He has contributed to the development and promotion of the artificial pancreas, critically developing device interoperability standards, analyzing user experience, and examining technical platforms. He has created numerous award-winning mobile health apps, including bant, an application designed for adolescents for the self-management for type 1 diabetes, which received the Stanford 2.0 Award. This work was also recognized by the Canadian Health Informatics Association, with their Excellence in Telehealth Award and the Dr. Mo Watanabe Lecture. Dr. Cafazzo is an associate professor at the University of Toronto, in the areas of clinical engineering, human factors, and health informatics and is the recipient of the Career Scientist award by the Ontario Min- istry of Health and Long Term Care. Thacher Hussain, Software Engineer & Advocate Thacher Hussain is passionate about helping patients to live better, more indepen- dent lives. She is a type 1 diabetic, a software engineer, and a healthcare strategy consultant -- bringing together the patient, the technical, and the strategic per- spectives. Turning her own diagnosis into the fuel for her work in patient advocacy, Thacher has spoken and written about her personal experience and takes an active role in seeking, designing, and building tools and solutions chronic patients. Having used both commercially available and open source solutions, Thacher continues to iterate on the system that serves her needs best. Above all she is a patient who is not waiting for a solution.
  10. 10. 2018 INNOVATION SUMMIT a fresh curriculum on diabetes innovation 11 patient innovation panel Aaron Sklar, Prescribe Design Aaron Sklar is Co-founder of Prescribe Design. Throughout his career, Aaron has led innovation teams through a human-centered design process focused on improving people’s quality of life, health and wellness. He spent several years in health-tech startups and 14 years at IDEO, an award-winning global design and innovation firm where he managed projects for more than 50 international organi- zations. Aaron has been published by the Rockefeller Foundation, Lancaster University’s “Design for Health” series, and in the HIMSS book Engage! Eric Hekler, UCSD Design Lab Dr. Eric Hekler, PhD, is an Associate Professor in the Department of Family Medi- cine & Public Health in the University of California, San Diego (UCSD), the Director of the Center for Wireless & Population Health Systems within the Qualcomm Institute at UCSD, and the faculty member of the Design Lab at UCSD. His research is broadly focused on advancing methods in the design, creation, op- timization, evaluation, and reuse (scaling up and out) of digital health technologies. His work is inherently transdisciplinary by advancing methods via melding approach- es from behavioral science/psychology, public health, human-computer interaction (HCI), control systems engineering, and computer science. There are three interde- pendent themes to his research for advancing. 1) methods for optimizing adaptive behavioral interventions; 2) methods and processes to help people help themselves: and 3) research pipe- lines to achieve efficient, rigorous, context-relevant solutions for complex problems. Relevant for this, Dr. Hekler has been supporting Dana Lewis, a person with type 1 diabetes who created the Open Artificial Pancreas System (www.openaps.org). Dr. Hekler is working with Ms. Lewis on a Robert Wood Johnson Foundation-funded project focused on opening pathways for innovation for patient-led work (www.openingpath- ways.org). Prior to UCSD, he was a professor at Arizona State University. Dr. Hekler completed his postdoctoral training at Stanford University and received his PhD in Clinical Health Psychology from Rutgers University. Jonathan Cluck, Jeff Innovation Design Lab Jon Cluck is a type 1 diabetic, anthropologist, educator, and open-source software hacker. Currently, he is an adjunct professor at Jefferson University and collab- orator with the JeffDesign program. His work is focused on non-institutionalized forms of life sciences and medical research, and examines contemporary shifts in expertise and scientific knowledge production. Jon received his PhD in Science & Technology Studies from Rensselaer Polytech- nic Institute, where his doctoral research involved a long-term multi-sited ethno- graphic study with a group of “biohackers” called do-it-yourself biology (DIYBio).
  11. 11. 12 DMU diabetesmine university Samantha Gottlieb, NSF Researcher Samantha D. Gottlieb, PhD, MHS, is the principal investigator of the National Sci- ence Foundation Science Technology and Society Scholars’ Award, “Fluid Sys- tems, Biologies, and Digital Activisms: The Open Source Data Movement Among Type 1 Diabetics (T1D).” Her work examines how policy, commercial development and patient advocacies respond to new health technologies. Her recent book, Not Quite a Cancer Vaccine, focuses on the diverse actors who shaped public acceptance of the human papillomavirus (HPV) vaccine in the U.S. after its widespread availability. She is an independent scholar who has taught at California State University, East Bay, and has been a Visiting Scholar at UC Berke- ley’s Center for Science, Technology, Medicine and Society.
  12. 12. 2018 INNOVATION SUMMIT a fresh curriculum on diabetes innovation 13 patient voices winners - dmu “teaching assistants” Kamil Armacki A T1D student in the UK, studying Accounting and Finance at Manchester Metropolitan University. He’s been involved in several CGM focus groups, and a year ago, decided to start his own YouTube channel called Nerdabetic, where he discusses and reviews new diabetes technology. He was recently selected to be a disability mentor at his university, mentoring a group of 10 disabled students starting this September. Additionally, MedAn- gel, makers of Bluetooth-enabled insulin thermometers, nominated him to take part in Young Patient Advocate program in Vienna this past summer. Cindy Campaniello A T2D in New York, who’s active with the DiabetesSisters group for women with dia- betes. She’s a former Sales and Bank Manager who says she was fired for diabetes in her last sales job (!). She writes: “Type 2’s need help. Desperately! ... CGMs are needed for type 2’s. I’m sick of doctor’s telling my DiabetesSisters to test in the morning only… whereas seeing your numbers climb from your diet would influence them more. Support is key to management. Phyllisa Deroze An American living in the United Arab Emirates, who was diagnosed with type 2 diabetes in 2011. She’s an Assistant Professor of English Literature by day and a diabetes advocate around the clock, blogging at diagnosedNOTdefeated.com. Her academic research high- lights feminist writers, but she say she’s “looking to move into medical narrative so that I can merge my academic interests with my advocacy.” Moira McCarthy This Massachussets D-Mom is a well-known writer, author, and speaker in the diabetes advocacy space. She tells us: “I have long been passionate about not just curing type 1 and developing better tools to treat it, but also about encouraging folks to live well with it AS we move toward those goals. In recent years, I’ve noticed a huge uptick in fear in the community, particularly among caregivers and parents of folks with T1D. I’ve been working on a concept and have begun speaking to folks (and device manufacturers) about it. I call it ‘Thoughtful Innovation; Compassionate Integration.’ What I mean by that is across the board embracing a strategy of building confidence as we roll out new tools and programs.” Terry O’Rourke A now-retired former avionics technician for a major commercial airline from Portland, OR. He was diagnosed with LADA (latent autoimmune diabetes in adults) at age 30 in 1984, and has seen many changes in diabetes tech and tools -- from early 80s urine glucose strips and insulin pumping, to finding support in the online community, and now using a CGM and even building his own do-it-yourself closed loop system. He also lives with a 10-year-old diabetes alert dog named Norm. “We need an industry of compas- sion, one that is confident enough to show new adopters that yes, these tools make life easier but no, you won’t be lingering on disaster for a bit without them,” Terry says. btw, he also lived on a sailboat for 15 years while living in the Bay Area.
  13. 13. 14 DMU diabetesmine university Claire Pegg A Colorado woman who is both living with type 1 herself and caring for her 85-year- old father who has T1D and is struggling with dementia. By day, she’s a Materials Dispatcher at Anythink Libraries, dealing with Collection Development and Inter- library Loans. In her private time, she’s been involved in clinical research trials for sotagliflozin and the Medtronic 670G system. She writes: “We will soon be facing a crisis because increased quality of care has led to type 1’s living far longer than they ever have. There is a very little residential care available for senior citizens with type 1, leaving families with no choices when their loved ones age. To quote an adminis- trator of a nursing home I was visiting, there was no one able to manage insulin and blood sugars ‘because diabetics are not supposed to live this long.’” Chelcie Rice A longtime T1D in Georgia who’s had a longstanding gig as a diabetes comedian. He’s passionate about attending the DiabetesMine event “because as an Afri- can-American living with diabetes and as an advocate I think it’s my responsibility to represent one of the groups of people who are largely affected by this chronic illness. For far too long there has been a disproportionate number of people of color participating or volunteering for health studies and panels. My attending would hopefully inspire others like me to become part of a solution.” Jim Schuler A T1D who’s a medical student at the Jacobs School of Medicine at the University at Buffalo in New York, preparing for a career as a pediatric endocrinologist. He writes: “Diabetes is the reason I am in medical school. Attending and being a counselor at diabetes camp made me choose to build my life around helping others... I wanted to do more than ‘just’ be a physician, however, and research is an avenue to do just that. One of my projects during my PhD years is analyzing data collected at diabetes camp to improve care for children with diabetes. Additionally, I am working on an interface for better collection of data, and keenly want to learn as much as possible about design and human factors engineering as it relates to diabetes.” He also runs support group for teenagers and young adults with diabetes called “D-Link” and is generally interested in how adolescents utilize technology. Stacey Simms This North Carolina based D-Mom is well-known as host and producer of Diabetes Connections, a weekly podcast for and about people with T1D. She produces the show through her company, Stacey Simms Media, and provides voice work for se- lect commercial and industrial clients. She also runs runs a local Facebook group of 500+ parents of T1D kids, where they can ask questions and share tips. One of her pet peeves is pump infusion sets: “They leak, they bend. There is no easy way to fig- ure out what size, shape, depth and inserter is right for you – you just have to buy a case and hope it works for you. There has to be a better way.” You’ll find Stacey on- site on Day 2 recording interviews about the ‘DiabetesMine University’ experience.
  16. 16. 8:10 8:45 Welcome to #DData! - host Amy Tenderich The FDA mHealth Pre-certification Program: What It Means for Diabetes Bakul Patel, FDA Assoc. Director of Digital Health, in conversation with participants from Fitbit, Tidepool and Verily Tidepool + Loop: Building an Interoperable Ecosystem Howard Look, Tidepool Coffee Break Blockchain in Healthcare: A Reality Check Deepak Gopalakrishna, Boston Consulting Group Digital Ventures An International View of Diabetes Innovation Niti Pall, Medical Director of KPMG’s Global Health Practice Lunch 10:00 10:20 10:45 11:30 12:00 1:00 1:30 2:00 3:30 4:30 4:40 2:30 DIY Diabetes Takes on Machine Learning Marius Eriksen, TinyAP How Machine Learning Fuels D-Industry Solutions Lane Desborough, Bigfoot Biomedical On Regulation & The Promise of Machine Learning Bill Evans, Rock Health CREATIVE TENSIONS: Discovering Your Stance on Machine Learning Led by IDEO MACHINELEARNING-360°SEMINAR Closing Remarks - Amy Tenderich TGIF Networking Hot New #DData Demos – with expert judges • Klue • Dance • DiaBits • SugarMate • bgAWARE • Diabeloop AGENDA DMU#DDATATECHNOLOGYEXCHANGE 3:15 Coffee Break
  18. 18. a fresh curriculum on diabetes innovation 19 #DDATA TECHNOLOGY EXCHANGE featured speakers Bakul Patel, FDA Bakul Patel is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA). Mr. Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information tech- nology. This includes responsibilities for mobile health, health information technol- ogy, cyber security, medical device interoperability, and medical device software. Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort. Before joining FDA, Mr. Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His expe- rience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fast- paced, technology-intensive organizations. Mr. Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University. Howard Look, Tidepool Howard is the President, CEO and Founder of Tidepool, an open source, not-for- profit effort to make diabetes data more accessible, actionable, and meaningful by liberating data from diabetes devices, supporting researchers, and providing great, free software to the diabetes community. Previously, Howard was on the founder’s team at TiVo where as VP of Software and User Experience he led the efforts that made TiVo as easy to use as it was disruptive. He was also VP of Software at Pixar, where he led the team developing Pixar’s proprietary film-making system, and at Amazon where he ran a software projects for cloud-connected devices. At Linden Lab, he led the team that deliv- ered the open-sourced Second Life Viewer 2.0 project. In 2015, Howard was awarded the White House Champions of Change award for Precision Medicine on behalf of Tidepool’s work. In 2016, Howard participated in a panel discussion with President Barack Obama at the Precision Medicine Initiative Summit at the White House. Howard has a BS in Computer Engineering from Carnegie Mellon University. He joined the diabetes community when his daughter was diagnosed with type 1 diabetes in 2011.
  19. 19. 20 DMU diabetesmine university Eric Friedman, Fitbit Eric is Co-Founder and has served as a member of the Fitbit board of directors since March 2007, and most recently as CTO. Previously, Eric served as an Engi- neer Manager at CNET Networks, as a Co-Founder of Wind-Up Labs, a founding engineer of Epesi Technologies, and a technical member of the Real-Time Collab- oration Group at Microsoft Corporation. Eric holds a B.S. and M.S. in Computer Science from Yale University. He was se- lected to serve as a member of Fitbit’s board of directors due to the perspective and experience he brings as our Co-Founder and CTO. Szymon Perkowski, Verily Szymon Perkowski is on a mission to get safe, effective, and innovative medical products to the market faster. He has 10 years of experience launching products and devices ranging from Class I to Class III in the medical device industry. He currently leads the software quality assurance group responsible for Software as a Medical Device (SaMD) and clinical platform compliance at Verily. Prior to Veri- ly, Szymon worked at Google deploying large enterprise software systems, as well as held positions at Cyberonics and Volcano. He holds a Master’s of Science in Chemical Engineering and quality and project management certifications through ASQ and PMI. Afia Asamoah, Verily Afia Asamoah is Senior Counsel, Product, Regulatory, and Policy at Verily Life Sci- ences, formerly Google Life Sciences, an Alphabet company. She leads the prod- uct counsel, policy, and regulatory affairs teams, reporting to the General Counsel. Prior to joining Google, Afia counseled pharmaceutical, biotechnology, and med- ical device clients on a range of healthcare, regulatory, and compliance issues at Covington & Burling LLP. From 2009-2011, Afia advised senior leaders and staff as a Special Assistant in the Office of the Commissioner at the U.S. FDA. She received four awards while at the agency, including the FDA Commissioner’s Special Citation. Afia received her undergraduate degree from Harvard University, Masters in Public Policy from the John F. Kennedy School of Government, and her Juris Doctor from Harvard Law School.
  20. 20. a fresh curriculum on diabetes innovation 21 #DDATA TECHNOLOGY EXCHANGE Deepak Gopalakrishna, Boston Consulting Group Deepak Gopalakrishna is Director at BCG Digital Ventures’ San Francisco and London offices where he is a core member of the pioneer blockchain projects. Deepak has deep expertise in digital innovation, venture capital and blockchain technology. He currently co-leads the development of Tracr, blockchain-based diamond trace- ability solution backed by De Beers. He also heads operations at DVolution, a BCG Digital Ventures-incubated pioneer of Decentralized Business Infrastructure. Prior to joining BCG Digital Ventures, Deepak founded two start-ups in medtech, and worked in venture capital in Silicon Valley and Boston. Niti Pall, KPMG Dr. Niti Pall servers as Medical Director of KPMG’s Global Health Practice in the UK. She is a visionary senior clinician who has combined clinical practice with an entrepreneurial edge to design and deliver new models of health care around the world. A general practitioner for over 30 years, Niti helped to build up the largest chain of primary care clinics in the UK – the Modality Partnership – and held several senior commissioning roles in the English NHS. She led the formation of Health India Private Ltd, a chain of primary care clinics across India later incorporated into HCL healthcare, where she subsequently worked as Chief Medical Officer. Most recent- ly she was Medical and Innovation Director of Emerging Markets for BUPA, where she helped to create an innovative model of micro-insurance in Bangladesh in partnership with Telenor. She established and supervised clinics in China, Saudi Arabia, Poland and Hong Kong and helped create health benefit management systems in India, Hong Kong, and Thailand. In India, she worked closely with the government and Max Bupa on RSBY a low cost health insurance scheme. In her current global role at KPMG, Niti leads our universal health coverage (UHC) work in Asia, as well as providing clinical leadership and primary care expertise across all work with KPMG’s Center for Universal Health Coverage.
  21. 21. 22 DMU diabetesmine university Marius Eriksen, TinyAP Marius is a Principal Engineer at GRAIL, a life sciences company dedicated to early cancer detection. Prior to GRAIL, Marius spent more than a decade working on computing and serving infrastructure at companies like Twitter and Google. After his daughter’s diagnosis of type 1 diabetes in 2015, he devoted his spare time developing an artificial pancreas (called “tinyAP”) based on the Animas Ping insulin pump and built a model-predictive controller using Google’s open source machine learning framework, Tensorflow. Lane Desborough, Bigfoot Biomedical Lane Desborough is Chief Engineer for Bigfoot Biomedical. Prior to co-founding Bigfoot in late 2014, Lane spent two decades implementing and remotely moni- toring automation in hazardous, complex chemical plants, mines, paper mills, oil refineries, and power plants all over the world. Lane’s industrial automation experience enabled him to jump immediately into the fight against type 1 diabetes when his son was diagnosed in 2009. He joined Medtronic Diabetes in 2010 and led the engineering team responsible for com- mercialization of the SmartGuard Predictive Low Glucose Management algo- rithm in the 640G and 670G. In his spare time while at Medtronic he co-created Nightscout and pioneered #WeAreNotWaiting. In fact, he was the first to utter the phrase “We Are Not Waiting” at the inaugural DiabetesMine D-Data ExChange at Stanford in November 2013; Howard Look asked the audience to summarize the community-led innovations they had just seen, Lane answered “We Are Not Waiting” and the rest is history. Lane is also a world champion open ocean sailboat racer, lean / agile practitioner and recreational mathe- matician. He lives with his family in Thousand Oaks, CA, but is a frequent visitor to the Bay Area. Bill Evans, Rock Health Bill serves as Rock Health’s CEO & Managing Director, leading the Rock Health team and working closely with portfolio companies. He joined Rock Health in 2017 following his departure from Roche Diagnostics where he was Senior Director of Product for Roche’s newly formed oncology decision-support business unit. Bill earned a Bachelor of Arts degree in Economics from Harvard University and began his career at Goldman Sachs before entering the startup world in Silicon Valley.
  22. 22. a fresh curriculum on diabetes innovation 23 #DDATA TECHNOLOGY EXCHANGE demo companies Continuous Glucose Monitors (CGM’s) are among the most powerful new technologies improving the quali- ty of life and clinical outcomes for a growing number of people with diabetes. And yet there are many situations like being in class or on a date, driving in a car or engaged in a meeting or sports event when loud, repetitive alarms and disruptive screen-watching just don’t work. Ironically it is often at times when physical or cognitive performance matter most, CGM users have to choose between staying aware of their blood glucose and risking the disruption or embarrassment of a loud alarm calling attention to them among their classmates, colleagues and friends. Though some customization is available, the current paradigm often leaves CGM users chasing highs and lows and suffering alarm fatigue. But what if we shifted this vital data stream from audio and visual alerts to the user’s sense of touch? Sub- tle, ongoing tactile input from your wrist, almost imperceptible when you’re steady and in range, but slowly ramping up in intensity and differentiation as you move towards the boundaries of your target numbers. This would allow you to stay on top of of your blood glucose without even having to look up from a task, or break eye contact with your date, or the road! Our design, built on the groundbreaking neuroscience of sensory augmentation, transforms blood glucose monitoring from one more item that diabetes interrupts your life, to a personal, discreet, ambient aware- ness of what’s happening with your body as a new sensory experience. creative tensions: discovering your stance on ai/machine learning INTERACTIVE SESSION LED BY
  23. 23. 24 DMU diabetesmine university Starting in 1990 the development of meal time inhaled insulin began in earnest. Since then many compa- nies invested extensively in developing inhaled insulin products and two dry powder products, Exubera and Afrezza finally received FDA approval in 2006 and 2014, respectively. Exubera was unfortunately with- drawn for “business reasons” which collapsed the development effort except for MannKind who pushed forward with Afrezza which is now on the market. Dance 501 is a clinical phase 2 development stage inhaled insulin delivery system that is comprised of a separate sterile preservative-free drop dispenser of liquid insulin, and a small silent, connected, breath-controlled, durable soft mist inhaler. Insulin dose is adjusted by the number of drops loaded into the device. There are two dosage strengths, 2U and 6U/drop. The absorption profile of the Dance 501 inhaled insulin in Type 1 and Type 2 patients mimics the natural insulin secretion response of the pancreas to a regular meal in healthy subjects. It is slightly faster in onset than Humalog but with a longer tail at the end similar to regular injected insulin. The Dance 501 insulin formulation was designed with lung compatibility in mind and exhibits virtually no cough. Small lights on the device guide the patient to inhale with the correct breathing maneuver and alert the patient when the dose is gone. Dance 501 is being developed globally whereby the same regulatory package will be submitted in parallel to the US, European and Chinese regulatory agencies. DiaBits is the first AI-powered glucose monitoring app. It is able to learn and predict users’ future glucose values 60 minutes ahead of time using heart rate and activity, in addition to insulin and glucose values. By measuring the variability in patient’s activity, heart rate, and glucose data, we defined different physio- logical states. We then use machine learning techniques to model glucose behavior based on these param- eters, and use the information to predict glucose behavior. To measure the predictive accuracy of our approach we recently tested our algorithm with the help of BC Children’s hospital (BCCH) in a blinded pilot study. During the study, 8 pediatric patients to used a continu- ous glucose monitor (CGM) and a Fitbit to generate a continuous 60-day patient-specific library of continu- ous activity, heart rate, and blood glucose data. ​ We presented our findings at the 78th American Diabetes Association Scientific Sessions in Orlando 2018, and published the results of how physiological data can be used to predict future glucose values with a reliable rate of accuracy a full hour in advance.
  24. 24. a fresh curriculum on diabetes innovation 25 #DDATA TECHNOLOGY EXCHANGE Klue has developed a hand gesture recognition technology that automatically deduces a user’s eating and drinking behaviors from monitoring his/her hand movements using existing wearable devices. Since the software operates in real-time, it can issue real-time alerts or send users personalized, in-the-moment tips or reminders that empower them to actively engage in their health. Our software acts as an interactive health assistant and provides a new type of wearable application that acts and interacts at exactly the right time to positively influence behavior and health outcomes. Klue has partnered with the Stanford School of Medicine to deliver an evidence-based solution and we are part- nering with companies across the health spectrum to co-develop and roll out new programs and solutions that leverage the groundbreaking capabilities of our platform. Our partners can use Klue’s API to integrate consumption activity information into their specific solutions. Klue’s meal detection capabilities hold great promise for improving the quality of life and health for individ- uals living with type 1 diabetes. Automatic meal detection paves the way for a fully autonomous closed loop artificial pancreas system. Furthermore, Klue is announcing the addition of a bolus reminder module to its suite of turnkey engagement modules. This new engagement module has been designed specifically for individuals with type 1 diabetes to help improve medication adherence and tighten glycemic control. Sugarmate is a free companion application for continuous glucose monitors that helps make it easier for users and parents to manage their diabetes. The app provides an infinite-scroll graph with customizable, real-time statistics and a voice-enabled activity feed for looking up nutritional information and tracking food, insulin, exercise and more. Sugarmate offers many new ways to help keep sugar levels under control, and uses a variety of methods to notify users of changes to their blood sugar readings, including: 1) Customizable Push Notifications: Predictive low and high alerts let users know before they get out of range, and the steady & above normal alert helps reminds users when to get back into range. 2) Phone Calls: Users can receive a call when they’re sleeping and their sugar dips below their normal range. This provides an additional safety net for users who don’t always wake up to their alerts and gives them and their loved ones some additional peace of mind. 3) Text Messages: Sugarmate can send an SMS to friends and family when a user’s sugar level becomes urgently low and lets them know their approximate location. 4) Apple Watch: The iOS app uses an innovative method of updating the Apple Watch to ensure that read- ings consistently refresh and always stay visible on the watch face, for both users and followers.
  25. 25. 26 DMU diabetesmine university Diabeloop is a French independent company developing disruptive technology to automate the treatment of Type 1 diabetes. Its first product, the DBLG1 System, is an integrated system that allows glycemic control in an automatic and highly efficient way. The core of this innovation is an Artificial Intelligence hosted on a terminal that connects via bluetooth with a continuous glucose meter (CGM) and an insulin pump. The algorithm makes and executes the many therapeutic decisions that patients currently have to handle by themselves. Patients are only expected to log meals and physical activities. Since 2015, Diabeloop has rapidly set up a dedicated team of 40+ people in charge of algorithm design, technical integration, regulatory management, industrialization, communication and market access. Part- nered with the CERITD led by Dr. Charpentier, Diabeloop medical director and founder, and with CEA-Leti leading university diabetes centers (French and international), Diabeloop has formed a unique combination of expertise in medical research, clinical development and deep math skills. Together, they have achieved a radical innovation, an algorithm that fine-tunes the glucose management in a proactive way thanks to personalization to the individual’s physiology, self-learning capabilities and integration to patients’ care path and everyday life.
  26. 26. a fresh curriculum on diabetes innovation 27 #DDATA TECHNOLOGY EXCHANGE demo judges Adam Brown, diaTribe Adam Brown serves as Head of Diabetes Technology & Connected Care at Close Concerns and Senior Editor at diaTribe.org. Adam brings 17 years of personal experience living with diabetes to all of his work, especially in covering new tech- nology like glucose meters, CGMs, insulin pumps, automated insulin delivery, and mobile apps. Adam writes an acclaimed column for diaTribe, Adam’s Corner, which has brought useful diabetes tips to over 1 million people since 2013. Adam’s first book, “Bright Spots & Landmines: The Diabetes Guide I Wish Someone Had Handed Me,” was published in May 2017 and received immediate praise for its actionable advice on food, mindset, exercise, and sleep. Adam has also brought a patient perspective to numerous public venues, including FDA and NIH meetings, scientific and industry conferences (ADA, AADE, IDF) and patient events (JDRF, TCOYD). He graduated summa cum laude from the Wharton School of the University of Pennsylvania in 2011 pursu- ing concentrations in marketing and health care management and policy. He is passionate about exercise, nutrition, psychology, and wellness, and spends his free time cycling in San Francisco. Phyllisa Deroze, Professor & Advocate Phyllisa is a South Florida native, Fulbright Scholar, and an American Literature professor currently living in the United Arab Emirates. She started blogging to share her experiences, make connections with other people living with diabetes since she’s the first person with diabetes from both sets of grandparents’ lineage, and create a web presence that provides culturally competent information about the effects of diabetes in black communities. She blogs at DiagnosedNOTdefeated.com and is the founder of Black Diabetic Info. She is also member of the The Type 2 Experience, and has published articles on HealthCentral, Everyday Health, and Health Union. Jessica Kirk, Mayo Clinic Jessica Kirk MSN, RN, CPN, CDE a diabetes educator and has lived with type 1 diabetes for over 25 years. Most recently she has been a nurse manager at the University of New Mexico Health Sciences Center leading a diabetes research grant focusing on type 1 diabetes in medically underserved communities. In this role, Jessica provides best practice diabetes self-management strategies to other healthcare professionals across the country. During her career she has been in- volved in diabetes programs in adult and pediatric populations. Jessica is an expert in diabetes technology such as insulin pumps and continuous glucose monitoring. She has joined the #WeAreNotWaiting movement and has built and uses a DIY automated insulin delivery system. She is an advocate for holistic diabetes management including psychosocial care of those living with diabetes.
  27. 27. info@diabetesmine.com